Evidence map›Paper›PMID 35137775›Full record

ArticleArquivos brasileiros de cardiologia2022

Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.

Bruno P Valdigem, Edileide B Correia, Dalmo A R Moreira, David Le Bihan, Ibraim Masciarelli Francisco Pinto, Alexandre A Cunha Abizaid, Rogério Braga Andalaft, Antonio Tito Paladino Filho, Halstead Alarcão Gomes Pereira da Silva, Joao Henrique Zucco Viesi

Open access · diamondAbstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bruno P ValdigemInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.ORCID 0000-0003-0676-2033
Edileide B CorreiaInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Dalmo A R MoreiraInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
David Le BihanInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.ORCID 0000-0002-1919-164X
Ibraim Masciarelli Francisco PintoInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Alexandre A Cunha AbizaidInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Rogério Braga AndalaftInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.ORCID 0000-0002-5168-8496
Antonio Tito Paladino FilhoInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Halstead Alarcão Gomes Pereira da SilvaInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Joao Henrique Zucco ViesiInstituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.
Instituto Dante Pazzanese de Cardiologia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypertrophic cardiomyopathy (HCM) can cause obstruction in the left ventricular outflow tract (LVOT), and be responsible for the onset of limiting symptoms, such as tiredness. When such symptoms are refractory to pharmacological treatment, interventionist alternative therapies can be useful, such as septal ablation through the infusion of alcohol in the coronary artery or through myectomy. Recently, the use of a radiofrequency (RF) catheter for endocardial septal ablation guided by electroanatomic mapping has proven to be efficient, despite the high incidence of complete atrioventricular block. An alternative would be the application of RF at the beginning point of the septal gradient guided by the transesophageal echocardiography (TEE). The echocardiography is an imaging method with high accuracy to determine septal anatomy.

objectiveTo assess the long term effect of septal ablation for the relief of ventricular-arterial gradient, using TEE to help place the catheter in the area of larger septal obstruction. Besides, to assess the effects of ablation on the functional class and echocardiographic parameters.

methodsTwelve asymptomatic patients, with LVOT obstruction, refractory to pharmacological therapy, underwent endocardial septal ablation with 8mm-tip catheters, whose placement was oriented in the region of larger obstruction, assisted by the TEE. Temperature-controlled and staggered RF applications were performed. After each application, the gradient was reassessed and a new application was performed according to the clinical criterion. The effects of RF applications were assessed both for the gradient at rest and for that provoked by the Valsalva maneuver, and considering the gradient. The differences were significant when p-value was lower than or equal to 0.05.

resultsIt was possible to observe that the mean reduction of the maximum gradients was from 96.8±34.7 mmHg to 62.7±25.4 mmHg three months after the procedure (p=0.0036). After one year, the mean of maximum gradient was 36.1±23.8 mmHg (p=0.0001). The procedure was well tolerated, without records of complete atrioventricular block nor severe complications.

conclusionThe TEE-guided septal ablation was efficient and safe, and the results were maintained during the clinical follow-up period. It is a reasonable option for the interventionist treatment of LVOT obstruction in HCM.

Indexed as

Atrioventricular BlockCardiomyopathy, HypertrophicCatheter AblationCathetersEchocardiographyHumansTreatment Outcome

Identifiers

PMID35137775
PMCPMC9368870
OpenAlexW3215543908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.